z-logo
open-access-imgOpen Access
NEK2, a promising target in TP53 mutant cancer
Author(s) -
Martina Cusan,
Lili Wang
Publication year - 2022
Publication title -
blood science
Language(s) - English
Resource type - Journals
ISSN - 2543-6368
DOI - 10.1097/bs9.0000000000000106
Subject(s) - biology , kras , cancer research , carcinogenesis , oncogene , gene duplication , cdkn2a , cancer , suppressor , gene , dna methylation , tumor suppressor gene , genetics , mutation , gene expression , cell cycle

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here